CBLL
CeriBell, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -30.0% ·
share flow -30.0% ·
net new positions -20.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 376.90K | -25.2% | $7.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 288.24K | +12.1% | $5.54M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | State Street Global Advisors ✦ (passive) | 218.35K | +40.9% | $4.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Marshall Wace ✦ | 31.21K | 0.0% | $599,640 | 0.0% | Held | 2 | SEC ↗ |
| 5 | Soros Fund Management ✦ | 25.36K | +1.4% | $487,089 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Adage Capital Partners | $8.23M | was 0.0% |
| Citadel Advisors | $5.34M | was 0.0% |
| Renaissance Technologies | $1.08M | was 0.0% |
| Norges Bank | $422,258 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 121 holders, 29.58M shares, $536.67M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.89K sh · $119,145
Officer, Director · 20.85K sh · $521,775
Officer · 846 sh · $21,150
Officer · 7.50K sh · $181,875
Officer · 1.75K sh · $42,576
Officer · 4.89K sh · $118,901
Officer · 652 sh · $16,300
Officer, Director · 39.54K sh · $973,079
Officer · 859 sh · $20,573
Officer, Director · 6.07K sh · $145,753
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology